Back
Return
Biography
Dr. Vikas Kumar
Dr. Vikas Kumar
BanarasHindu University, India

Doctor


Email: vikas.phe@itbhu.ac.in


Qualifications
2001 Ph.D., Banaras Hindu University
1997 M.Pharm./M.S., Gulbarga University
1995 B.Pharm./B.S., Gulbarga University

1991 D.Pharm., Bangalore Board


Publications (Selected)
  1. Singh, A., Dubey, S.D., Patne, S., Kumar, V. 2010. Acute and sub-chronic toxicity study of calcium based ayurvedic ‘Bhasmas’ and a ‘Pishti’ prepared from marine-sourced animals.Journal of Herbal Medicine and Toxicology4 (1): 35-47.
  2. HusainGM, Singh PN, Kumar V. 2009.Antidiabetic activity of standardized extract ofPicrorhiza kurroain rat model of NIDDM.Drug Discoveries & Therapeutics3(3): 88-92.
  3. Mishra, D., Sinha, M., Kumar, V. 2009. Teratological study of ‘Garbhpal Ras’, an Ayurvedic medicine.Journal of Herbal Medicine and Toxicology3(1): 37-40.
  4. Husain, G.M., Chatterjee, S.S., Singh, P.N., Kumar, V. 2009. Antiaggressive activity of standaridised extract of IndianHypericum perforatumL.Pharmacologyonline1: 432-444.
  5. Kiewert, C., Kumar, V., Hildmann O., Ruda, M., Hartman, J., Hillert, M., Klein, J. 2008.Role of glycine receptors and glycine release for the neuroprotective activity of bilobalide.Brain Research1201: 143-150.
  6. Mishra, S., Khanna, V.K., Kumar, V. 2008. Benzodiazepine receptor binding and anxiolytic studies on Anximin®, a polyherbal formulation.Journal of Cell and Tissue Research8(3): 1491-1498.
  7. Kiewert, C., Kumar, V., Hildmann O., Ruda, M., Hartman, J., Naik, R., Klein, J. 2007. Role of GABAergic antagonism for the neuroprotective effects of bilobalide.Brain Research1128: 70-78.
  8. Mdzinarishvili, A.,  Kiewert, C.,  Kumar, V.,  Hillert, M., Klein, J. 2007.Bilobalide prevents ischemia-induced edema formation in vitro and in vivo.Neuroscience144: 217-222.
  9. Kumar V., Naik, R.S., Hillert, M., Klein J. 2006.Effects of chloride flux modulators in an in vitro-model of brain edema formation.Brain Research.1122: 222-229.
  10. Kumar, V. 2006. Potential medicinal plants for CNS disorders.Phytotherapy Research20: 1023-1035.
  11. Kumar, V., Mdzinarishvili, A, Kiewert, C, Abbruscato, T, Bickel, U, Schyf, CJ, Klein, J. 2006. NMDA receptor-antagonistic properties of hyperforin, a constituent of St. John’s wort.Journal of Pharmacological Sciences102: 47-54.
  12. Das, S.N., Kumar, V.,Mathur, A.K., Agrawala, S.K. 2005. Teratological study of NefroLiv.Phytomedica6: 117-122.
  13. KumarV., Agrawala, S.K.,Bhattacharya, S.K. 2004. Behavioural studies onHypericum perforatumformulations.Phytomedica5: 19-30.
  14. Kumar, V., Das, S.N., Rao, A.T, Agrawala, S.K. 2003. Chronic toxicity study of herbo-mineral EHb.Phytomedica4: 111-116.
  15. Kumar, V., Khanna, V.K., Seth, P.K., Singh, P.N., Bhattacharya, S.K. 2002. Brain neurotransmitter receptor binding and nootropic studies on IndianHypericum perforatumLinn.Phytotherapy Research16: 210-216.
  16. Kumar, V., Singh, P.N., Bhattacharya, S.K. 2001. Neurochemical studies on IndianHypericum perforatumLinn.Indian Journal of Experimental Biology39: 334-338.
  17. Kumar, V., Singh, P.N., Muruganandam, A.V., Bhattacharya, S.K. 2000. Effect of IndianHypericum perforatumLinn on animal models of cognitive dysfunction.Journal of Ethnopharmacology72: 119-128.
  18. Kumar, V., Singh, P.N., Jaiswal, A.K., Bhattacharya, S.K. 1999. Antidepressant activity of Indian HypericumperforatumLinn in rodents.Indian Journal of Experimental Biology37: 1171-1176.